© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Cleveland Clinic
Latest from Cleveland Clinic
Grading Valuable Aspects of Mesenchymal Cell Activity in Progressive MS: Jeffrey Cohen, MD
October 14, 2021
Video
The director of the Mellen Center for MS Treatment and Research at Cleveland Clinic provided context on whether efficacy outcomes should be weighed more than mechanistic action when evaluating MSC-NTF cell therapies. [WATCH TIME: 3 minutes]
Benefits to Treating Progressive MS With Mesenchymal Stem Cells: Jeffrey Cohen, MD
October 13, 2021
Video
The director of the Mellen Center for MS Treatment and Research at Cleveland Clinic discussed the use of MSC-NTF cells in progressive MS and the data backing this approach. [WATCH TIME: 3 minutes]
Prioritizing Women and Genetics in Alzheimer Disease Trials: Jessica Caldwell, PhD
October 06, 2021
Video
The director of the Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic discussed the role genetics play in Alzheimer disease and the importance for all-women trials. [WATCH TIME: 2 minutes]
Emphasizing Gender and Genetic Differences in Alzheimer Disease Trials
September 27, 2021
Article
Jessica Caldwell, PhD, director, Women’s Movement Prevention Center, Cleveland Clinic, sat down shed light on the understanding of Alzheimer disease in women and their inclusion in clinical trials.
Improving Alzheimer Disease Trials With Genetics: Jessica Caldwell, PhD
September 23, 2021
Video
The director of the Women’s Prevention Center at Cleveland Clinic discussed why understanding genetics may help drug development of Alzheimer disease treatments. [WATCH TIME: 2 minutes]
NeuroVoices: Jessica Caldwell, PhD, on the Association of Genetics and Alzheimer Disease
September 22, 2021
Article
The director of the Women’s Movement Prevention Center at Cleveland Clinic discussed her new study, and the current knowledge of the role genetics play in Alzheimer disease risk.